Flow cytometric quantitation of calcium-dependent and -independent mitogen-stimulation of T cell functions in whole blood: inhibition by immunosuppressive drugs in vitro (Q43625131)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Flow cytometric quantitation of calcium-dependent and -independent mitogen-stimulation of T cell functions in whole blood: inhibition by immunosuppressive drugs in vitro	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

25 November 2017

Flow cytometric quantitation of calcium-dependent and -independent mitogen-stimulation of T cell functions in whole blood: inhibition by immunosuppressive drugs in vitro (English)

1 reference

Europe PubMed Central

25 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Barten MJ

1

1 reference

Europe PubMed Central

25 November 2017

Gummert JF

2

1 reference

Europe PubMed Central

25 November 2017

van Gelder T

3

1 reference

Europe PubMed Central

25 November 2017

Shorthouse R

4

1 reference

Europe PubMed Central

25 November 2017

Morris RE

5

1 reference

Europe PubMed Central

25 November 2017

publication date

1 July 2001

1 reference

Europe PubMed Central

25 November 2017

Journal of Immunological Methods

1 reference

Europe PubMed Central

25 November 2017

253

1 reference

Europe PubMed Central

25 November 2017

1-2

1 reference

Europe PubMed Central

25 November 2017

95-112

1 reference

Europe PubMed Central

25 November 2017

The effect of the immunosuppressant FK-506 on alternate pathways of T cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900369-6

7 January 2021

Whole-blood lymphocyte cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900369-6

7 January 2021

Whole blood culture for measuring mitogen induced T cell proliferation provides superior correlations with disease state and T cell phenotype in asymptomatic HIV-infected subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900369-6

7 January 2021

Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: tacrolimus (FK506), sirolimus (rapamycin), mycophenolate mofetil and leflunomide

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900369-6

7 January 2021

Cyclin: a nuclear protein whose level correlates directly with the proliferative state of normal as well as transformed cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900369-6

7 January 2021

Ex vivo assessment of immunosuppression in undiluted whole blood from pigs dosed with tacrolimus (FK506)

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900369-6

7 January 2021

Effects of leflunomide and other immunosuppressive agents on T cell proliferation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900369-6

7 January 2021

Pharmacodynamics of immunosuppressive drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900369-6

7 January 2021

Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900369-6

7 January 2021

Novel method for the measurement of cytokine production by a one-stage procedure

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900369-6

7 January 2021

Proliferation and interferon production in whole blood samples and isolated lymphocyte preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900369-6

7 January 2021

Optimizing whole blood lymphocyte proliferation in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900369-6

7 January 2021

Gender-related assessment of cyclosporine/prednisolone/sirolimus interactions in three human lymphocyte proliferation assays

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900369-6

7 January 2021

Differential regulation by dexamethasone and cyclosporine of human T cells activated by various stimuli

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900369-6

7 January 2021

A new method for measuring lymphoproliferation at the single-cell level in whole blood cultures by flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900369-6

7 January 2021

Preliminary results of clinical renal allograft transplantation in the dog and cat.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900369-6

7 January 2021

Effect of anesthesia on a whole blood lymphocyte proliferation assay in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900369-6

7 January 2021

Pharmacodynamics of mycophenolic acid in heart allograft recipients: correlation of lymphocyte proliferation and activation with pharmacokinetics and graft histology

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900369-6

7 January 2021

Transmembrane signalling by the T cell antigen receptor. Perturbation of the T3-antigen receptor complex generates inositol phosphates and releases calcium ions from intracellular stores

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900369-6

7 January 2021

The B7 and CD28 receptor families

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900369-6

7 January 2021

Early calcium signaling and calcium requirements for the IL-2 receptor expression and IL-2 production in stimulated lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900369-6

7 January 2021

A whole-blood lymphoproliferation assay for measuring cellular immunity against herpes viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900369-6

7 January 2021

The role of the CD28 receptor during T cell responses to antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900369-6

7 January 2021

T-cell receptor stimulation elicits an early phase of activation and a later phase of deactivation of the transcription factor NFAT1.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900369-6

7 January 2021

Anti-CD28 antibody- and IL-4-induced human T cell proliferation is sensitive to rapamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900369-6

7 January 2021

Cell adhesion in the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900369-6

7 January 2021

Divergent effects of rapamycin on mouse and rat cells following mitogenic stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900369-6

7 January 2021

Inhibition of phytohaemagglutinin-induced lymphocyte proliferation by immunosuppressive drugs: use of whole blood culture

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900369-6

7 January 2021

Selenium and vitamin E deficiency impair transferrin receptor internalization but not IL-2, IL-2 receptor, or transferrin receptor expression

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900369-6

7 January 2021

Interleukin-2 receptor (CD25) upregulation on human T-lymphocytes: sensitivity to immunosuppressants is defined by the mode of T-lymphocyte activation

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900369-6

7 January 2021

Mechanism of transferrin receptor down-regulation in K562 cells in response to protein kinase C activation

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900369-6

7 January 2021

The mechanism of action of cyclosporin A and FK506

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900369-6

7 January 2021

Rapamune® (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900369-6

7 January 2021

Leflunomide and malononitrilamides

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900369-6

7 January 2021

In vitro and in vivo effects of leflunomide, brequinar, and cyclosporine on pyrimidine biosynthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900369-6

7 January 2021

Flow cytometric analysis of the molecular mechanisms of immunosuppressive action of the active metabolite of leflunomide and its malononitrilamide analogues in a novel whole blood assay

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900369-6

7 January 2021

The IL-2/IL-2 receptor system: a current overview

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900369-6

7 January 2021

Sequential monitoring of peripheral blood lymphocyte subsets in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900369-6

7 January 2021

Early steps of lymphocyte activation bypassed by synergy between calcium ionophores and phorbol ester

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900369-6

7 January 2021

Pharmacological inhibition of CD28-stimulated T cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900369-6

7 January 2021

A convenient human whole blood culture system for studying the regulation of tumour necrosis factor release by bacterial lipopolysaccharide.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900369-6

7 January 2021

Two activities of the immunosuppressive metabolite of leflunomide, A77 1726. Inhibition of pyrimidine nucleotide synthesis and protein tyrosine phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900369-6

7 January 2021

Blood distribution of rapamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900369-6

7 January 2021

Identifiers

10.1016/S0022-1759(01)00369-6

1 reference

Europe PubMed Central

25 November 2017

1 reference

Europe PubMed Central

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43625131&oldid=2101960347"